WHY WE CARE
Our goal is to ensure the promise of breakthrough technologies and clinical research insights can be made accessible as quickly as possible to all those diagnosed with cancer.
We focus on brain cancer and childhood cancers, where barriers exist around equal access to new treatments and funding is limited.
We support the implementation and scale-up of genomic screening to establish personalised cancer care pathways, and provide more treatment options by funding clinical trials of targeted treatments or emerging therapeutics, including into rural, remote or poorly served communities.
Minderoo 5G Platform Trial for Brain Tumours
Offering access to new and promising therapeutics through ‘A next Generation AGile Genomically-Guided Glioma Modular Platform Trial for Molecular Therapy in Brain Cancer’ (5G).
Zero Childhood Cancer Precision Medicine Program (ZERO)
Scaling our collaboration to ensure every child in Australia diagnosed with cancer can access comprehensive genomic profiling and personalised treatment recommendations. ZERO identifies less toxic and more targeted treatments that give the best chance of survival and help to avoid long-term health problems.